Viewing Study NCT02062359


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-02-08 @ 2:45 PM
Study NCT ID: NCT02062359
Status: TERMINATED
Last Update Posted: 2016-06-24
First Post: 2014-02-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
Sponsor:
Organization: